BNA Trademark

Trademark Overview


On Monday, May 27, 2024, a trademark application was filed for BNA with the United States Patent and Trademark Office. The USPTO has given the BNA trademark a serial number of 79405159. The federal status of this trademark filing is RESPONSE AFTER NON-FINAL ACTION - ENTERED as of Thursday, July 3, 2025. This trademark is owned by RIKEN GENESIS CO., LTD.. The BNA trademark is filed in the Treatment & Processing of Materials Services category with the following description:

Custom manufacture of nucleic acids for chemical diagnostic reagents for scientific purposes; custom manufacture of nucleic acids for chemical preparations for diagnostic and scientific purposes; custom manufacture of nucleic acids for chemicals for industrial use, other than for medical or veterinary use; custom manufacture of nucleic acids for reagents for use in genetic research, other than for medical or veterinary use; custom manufacture of nucleic acid drugs; custom manufacturing of molecule RNA drugs; custom manufacture of nucleic acids for diagnostic reagents and diagnostic preparations for medical use; custom manufacture of nucleic acids for diagnostic biomarker reagents; custom manufacture of nucleic acids for reagents for genetic test for medical use
bna

General Information


Serial Number79405159
Word MarkBNA
Filing DateMonday, May 27, 2024
Status661 - RESPONSE AFTER NON-FINAL ACTION - ENTERED
Status DateThursday, July 3, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesCustom manufacture of nucleic acids for chemical diagnostic reagents for scientific purposes; custom manufacture of nucleic acids for chemical preparations for diagnostic and scientific purposes; custom manufacture of nucleic acids for chemicals for industrial use, other than for medical or veterinary use; custom manufacture of nucleic acids for reagents for use in genetic research, other than for medical or veterinary use; custom manufacture of nucleic acid drugs; custom manufacturing of molecule RNA drugs; custom manufacture of nucleic acids for diagnostic reagents and diagnostic preparations for medical use; custom manufacture of nucleic acids for diagnostic biomarker reagents; custom manufacture of nucleic acids for reagents for genetic test for medical use

Classification Information


International Class040 - Treatment of materials.
US Class Codes100, 103, 106
Class Status Code6 - Active
Class Status DateFriday, September 27, 2024
Primary Code040
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameRIKEN GENESIS CO., LTD.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressJP

Trademark Events


Event DateEvent Description
Thursday, September 26, 2024SN ASSIGNED FOR SECT 66A APPL FROM IB
Friday, September 27, 2024LIMITATION FROM ORIGINAL APPLICATION ENTERED
Wednesday, October 2, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, October 2, 2024APPLICATION FILING RECEIPT MAILED
Saturday, November 23, 2024CORRECTION TRANSACTION RECEIVED FROM IB
Tuesday, December 10, 2024ASSIGNED TO EXAMINER
Wednesday, December 18, 2024NON-FINAL ACTION WRITTEN
Saturday, January 11, 2025NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Saturday, January 11, 2025REFUSAL PROCESSED BY MPU
Thursday, December 19, 2024NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Friday, April 25, 2025ATTORNEY REVIEW COMPLETED
Saturday, February 1, 2025REFUSAL PROCESSED BY IB
Wednesday, April 16, 2025CORRECTION FROM IB ENTERED - ATTORNEY REVIEW REQUIRED
Thursday, July 3, 2025CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, July 3, 2025TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, July 3, 2025TEAS/EMAIL CORRESPONDENCE ENTERED